Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes

AIM: To compare day‐to‐day and within‐day variability in glucose‐lowering effect between insulin degludec (IDeg) and insulin glargine 300 U/mL (IGlar‐U300) in type 1 diabetes. MATERIALS AND METHODS: In this double‐blind, crossover study, patients were randomly assigned to 0.4 U/kg of IDeg or IGlar‐U...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Obes Metab
Auteurs principaux: Heise, Tim, Nørskov, Marianne, Nosek, Leszek, Kaplan, Kadriye, Famulla, Susanne, Haahr, Hanne L.
Format: Artigo
Langue:Inglês
Publié: Blackwell Publishing Ltd 2017
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485013/
https://ncbi.nlm.nih.gov/pubmed/28295934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12938
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires